Delivery Order SPE2DB22D1002-SPE2DB25FLAD9
Award Date
4/1/25
Potential Completion Date
4/2/25
Potential Value
$4.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Copaxone 40 mg/mL syringes. The contract has a ceiling value of $5,795.66 and a performance period extending through May 12, 2025. It is a firm fixed-price, non-set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of COPAXONE 40 MG/ML SYRINGEML, a medication used to treat relapsing forms of multiple sclerosis. The contract has a ceiling value of $3,350.74 and runs through January 17, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation (AmerisourceBergen), a major pharmaceutical distributor. The contract is for the supply of Copaxone 40 mg/mL syringes, a specialty medication. The delivery order has a ceiling value of $1,055.52 and a completion date of September 24, 2024. This award is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,678.46 and is for the delivery of COPAXONE 40 MG/ML syringes. The contract is a Firm Fixed Price, Delivery Order type and does not have a set-aside designation, indicating open competition. AmerisourceBergen also holds a larger Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,258.24, is a delivery order for the supply of Copaxone 40 mg/mL syringes, a specialty medication. The contract has a firm-fixed price pricing type and an ultimate completion date of July 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Medical to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of Copaxone 40 mg/mL syringes, a medication used to treat relapsing forms of multiple sclerosis. The contract has a ceiling value of $1,583.28 and a completion date of April 30, 2024. It is a firm-fixed-price delivery order contract, without any set-aside designation....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of COPAXONE 40 MG/ML SYRINGEML, a pharmaceutical product. The contract has a ceiling value of $4,749.84 and a completion date of July 29, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to efficiently procure a...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COPAXONE 40 MG/ML SYRINGEML, a pharmaceutical product, with a ceiling value of $9,350.47 and a period of performance through May 6, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Copaxone 20 mg/mL syringes, a medication used to treat multiple sclerosis. The contract is a firm fixed-price, non-set-aside award with a ceiling value of $1,199.67 and a period of performance through April 10, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation for the supply of COPAXONE 40 MG/ML syringes. The contract has a ceiling value of $3,166.62 and is a firm fixed-price contract. There is no set-aside designation for this award. AmerisourceBergen, a major pharmaceutical distributor, leverages its extensive supply chain network to provide a wide range of pharmaceutical products and medical supplies to support...